Christopher Counter, PhD, associate director of Basic Research, is a member of a group receiving an international Cancer Grand Challenges Grant to investigate origins of cancer.
DCI cancer disparities and healthcare delivery researchers Steven Patierno, PhD, and Nadine Barrett, PhD, are part of national efforts to mitigate cancer health disparities.
Three DCI faculty and physician leaders are utilizing their talents in new roles to ensure DCI patients continue to have the safest and best-quality care possible.
The Duke Cancer Institute is excited to announce the establishment of the Duke Sarcoma Center, a center of excellence for sarcoma treatment and research.
The risk of dying from cancer continues to drop at an accelerated pace. Some of this drop appears to be related to lung cancer patients living longerafter diagnosis.
The U.S. Senate confirmation of Robert Califf, MD, as FDA Commissioner was hailed by his colleagues in the world of clinical research and academic medicine.
Susan Dent, MD, FRCPC, associate director, Clinical Research, DCI Breast Cancer Disease Group, has joined the Duke IBC Consortium as clinical director.
Looking for a great read on how to develop, integrate, & implement a comprehensive cancer center? A new open-access book co-authored by Nelson Chao, MD, MBA, is now available.
Holly Dressman has been named director of Duke’s Sequencing and Genomic Technologies (SGT) Core Facility. Nicolas Devos, PhD, has stepped down from his role as SGT director.
Community outreach & engagement teams from DCI, Wake Forest and UNC cancer centers have launched an initiative focused on the cancer-related health needs of American Indian communities.
Former Blue Devil Maggie DiNome, MD, a breast surgical oncologist, joined Duke from UCLA as medical director of Wake County Breast Cancer Services and as a professor of Surgery.
Haley Moss, MD, MBA, will work to expand access to care for women veterans through teleoncology and clinical trials in new role at the U.S. Dept. of Veterans Affairs.
In his new NIH role, Ginsburg will help direct the national scientific research agenda to improve health and accelerate research using precision medicine.
Sydnee Crankshaw, MPA, has been named Senior Research Program Leader for DCI’s "Cancer Prevention and Control" and "Cancer Risk, Detection, and Interception" programs.
The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.
The $3 million National Science Foundation grant is for training Master’s and PhD students at Duke in engineering, computer science, data science, & surgical technologies.
Dukes receives two large grants totaling nearly $12 million from the National Human Genome Research Institute (NHGRI) as part of its new Impact of Genomic Variation on Function (IGVF) Consortium.
The new Duke Blood Cancer Center opens up the opportunity to transition some cancer treatments from the inpatient to the outpatient setting and the infusion room is open every day.
DCI's Melanoma (and advanced skin cancer) Disease Group expands Clinic 5-1 services to include dermatological cancer care for patients who require multidisciplinary care.
DCI scientist Ehsan Samei, PhD, Professor of Radiology, Physics, Biomedical Engineering, and Electrical and Computer Engineering, is director of the Center for Virtual Imaging Trials.